The COVID-19 pandemic has thrust RNA as a platform for drug development into the spotlight. However, identifying promising drug candidates is challenging. With advances in synthetic biology and artificial intelligence (AI) models, we can overcome this hurdle, transforming drug development and ushering in a new era in the pharmaceutical industry.
Keywords: RNA; artificial intelligence; drug development; synthetic biology.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.